3 research outputs found
ACTwatch 2009 Supply Chain Survey Results, Benin
In Benin, as in many low‐income countries, private commercial providers play an important role in
the treatment of malaria. To design effective interventions for improved access to accurate
diagnosis and effective malaria treatment, there is a need to understand retailer behaviour and
identify the factors that influence their stocking and pricing decisions. Private commercial retailers
are the last link in a chain of manufacturers, importers and wholesalers and their supply sources are
likely to have an important influence on the price and quality of malaria treatment that consumers
can access. However, there is limited rigorous evidence on the structure and operation of the
distribution chain for antimalarial drugs that serves the retail sector.
The ACTwatch Supply Chain Study, one of the ACTwatch project components, aims to address this
gap by conducting quantitative and qualitative studies on distribution chains for antimalarials in the
ACTwatch countries (Benin, Cambodia, the Democratic Republic of Congo (DRC), Madagascar,
Nigeria, Uganda and Zambia). Other elements of ACTwatch include Retail Outlet and Household
Surveys led by Population Services International (PSI). This report presents the results of a cross‐
sectional survey of antimalarial drug wholesalers conducted in Benin in June 2009
A Qualitative Assessment of the Private Sector Antimalarial Distribution Chain in Benin, 2009
In Benin, as in many low‐income countries, private commercial providers play an important role in the
treatment of malaria. To design effective interventions for improved access to accurate diagnosis and
effective malaria treatment, there is a need to understand retailers' behaviour and identify the factors that
influence their stocking and pricing decisions. Private commercial retailers are the last link in a chain of
manufacturers, importers and wholesalers, and their supply sources are likely to have an important
influence on the price and quality of malaria treatment that consumers can access. However, there is
limited rigorous evidence on the structure and operation of the distribution chain for antimalarial drugs that
serves the retail sector.
The ACTwatch Supply Chain Study, one of the ACTwatch project components, aims to address this gap by
conducting quantitative and qualitative studies on distribution chains for antimalarials in the ACTwatch
countries (Benin, Cambodia, the Democratic Republic of Congo (DRC), Madagascar, Nigeria, Uganda and
Zambia). This report presents the results from qualitative interviews with antimalarial drug wholesalers,
retailers and other key stakeholders conducted in Benin in June 2009. To provide a complete description of
the supply chain for antimalarial drugs, this report should be read in conjunction with the report on the
results of the structured supply chain survey also conducted as part of this study, available at
www.actwatch.info
A Qualitative Assessment of the Private Sector Antimalarial Distribution Chain in Benin, 2009
In Benin, as in many low‐income countries, private commercial providers play an important role in the
treatment of malaria. To design effective interventions for improved access to accurate diagnosis and
effective malaria treatment, there is a need to understand retailers' behaviour and identify the factors that
influence their stocking and pricing decisions. Private commercial retailers are the last link in a chain of
manufacturers, importers and wholesalers, and their supply sources are likely to have an important
influence on the price and quality of malaria treatment that consumers can access. However, there is
limited rigorous evidence on the structure and operation of the distribution chain for antimalarial drugs that
serves the retail sector.
The ACTwatch Supply Chain Study, one of the ACTwatch project components, aims to address this gap by
conducting quantitative and qualitative studies on distribution chains for antimalarials in the ACTwatch
countries (Benin, Cambodia, the Democratic Republic of Congo (DRC), Madagascar, Nigeria, Uganda and
Zambia). This report presents the results from qualitative interviews with antimalarial drug wholesalers,
retailers and other key stakeholders conducted in Benin in June 2009. To provide a complete description of
the supply chain for antimalarial drugs, this report should be read in conjunction with the report on the
results of the structured supply chain survey also conducted as part of this study, available at
www.actwatch.info